MedTrace Logo

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

NCT01076751 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2011-02-14

No results posted yet for this study

Summary

Primary Objective:

* Describe real-life survival of CRPC patients who received first-line docetaxel and have disease progression

Secondary Objective:

* Describe treatment patterns
* Describe the characteristics and outcomes of patients who received second-line taxane-based treatment compared to others
* Describe economic and patient-reported outcomes

Conditions

  • Prostatic Neoplasms

Sponsors & Collaborators

Principal Investigators

  • Clinical Sciences & Operations · Sanofi

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States
  • France
  • Germany
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076751 on ClinicalTrials.gov